$54.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Cartalax 20mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Cartalax 20mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | Not officially assigned (peptide bioregulator complex) |
|---|---|
| Molecular Formula | Peptide complex (exact structure proprietary) |
| Molecular Weight | Varies (approx. low molecular weight peptide fraction) |
| Purity | ≥99% |
| Sequence | Not publicly disclosed (peptide complex derived from calf cartilage) |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water/Sterile Diluent |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Applications | Cartilage regeneration, joint health research, musculoskeletal tissue studies |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Cartalax online should evaluate Cartalax as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, Cartalax purity documentation, batch-specific COAs, lot traceability, RUO labeling, storage information, and supplier transparency. Pure Lab Peptides presents Cartalax 20mg for qualified research procurement, with attention to COA review, identity testing, product form, and documentation before any laboratory purchase decision.
Researchers can buy Cartalax online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy Cartalax online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the search query relates to how qualified researchers, laboratory buyers, technical procurement teams, and research institutions evaluate a Cartalax research material before purchase. The focus is not use, outcomes, administration, or personal experimentation. The focus is documentation.
For RUO procurement, researchers should evaluate whether the supplier clearly separates research materials from consumer-use positioning. That means reviewing research-use-only labeling, batch-specific COA availability, purity documentation, Cartalax identity testing, product-form statements, storage documentation, lot traceability, and supplier language. FDA guidance on research-use-only and investigational-use-only labeling in the IVD context emphasizes that labeling and promotional context should align with intended use; while that guidance is not a product-specific approval for Cartalax, it is useful as a documentation and labeling reference point for research procurement teams [1].
Cartalax is commonly associated in chemical database records with alanyl-glutamyl-aspartic acid, also represented as Ala-Glu-Asp or AED. PubChem identifies alanyl-glutamyl-aspartic acid with the molecular formula C12H19N3O8 and a listed molecular weight of 333.29 g/mol [2]. ChEBI-linked ontology records place Ala-Glu-Asp within oligopeptide classification, which supports treating Cartalax as a short peptide research material for procurement and identity-review purposes [3].
Because Cartalax is best handled as a short peptide or bioregulator-category research material, the appropriate procurement lens is narrow: sequence or molecular identity, purity documentation, analytical testing, lot-level traceability, storage documentation, and RUO labeling. Published short-peptide literature discusses ultrashort peptide characterization, transporter-model hypotheses, and gene-expression research contexts, but those publications should not be converted into product-use claims for an RUO material [4] [5] [6].
Short peptide research literature should be discussed as scientific context, not as product-use guidance. Laboratory documentation may include the compound name, sequence or molecular identifier, formula, molecular weight, product form, lot number, stated purity, analytical method, and storage information. Those items help researchers evaluate whether a listed Cartalax research-use-only material matches the documentation required for controlled laboratory recordkeeping.
Researchers may search “buy Cartalax online” to compare RUO product availability, supplier documentation standards, COA access, purity support, identity information, and lot traceability. A laboratory buyer searching to buy Cartalax is usually trying to determine whether the material can be evaluated with enough documentation for internal procurement review, not whether it has consumer-facing claims.
Strong supplier documentation should help a research team answer practical questions before purchase: Is the material labeled for research use only? Is a batch-specific Cartalax COA available? Does the COA connect to the same lot number as the product label? Does the documentation include purity data and identity testing? Is the product form described as lyophilized powder? Are storage and handling expectations documented clearly enough for laboratory records?
Researchers should also review supplier language. A supplier that emphasizes documentation, analytical methods, RUO labeling, and transparent lot records is better aligned with laboratory procurement than a supplier that centers claims about results, personal outcomes, or unsupported use cases. For Cartalax research-use-only procurement, supplier documentation is a stronger quality signal than broad promotional wording.
When researchers evaluate where to buy Cartalax online for laboratory research, the strongest quality signals are documentation-based. Analytical procedure validation guidance describes identity, impurity, and assay-related purposes for analytical procedures, which is why procurement teams should read a COA as part of a broader identity and quality-review workflow rather than as a standalone marketing claim [7].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
A Cartalax COA should be read as part of a complete documentation package. Researchers should review the compound name, lot number, test date, stated purity percentage, testing method, identity confirmation, molecular weight where relevant, sequence or molecular identity where relevant, chromatogram or mass data where available, product form, and storage documentation. ICH Q14 describes analytical procedure development as a science- and risk-based activity, which reinforces why method context matters when researchers interpret analytical documentation [8].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. For peptide and short-peptide materials, HPLC and LC-MS-related workflows can support characterization by separating compounds and producing mass-based identity information. LC-MS/MS and related mass-spectrometry approaches are widely used in peptide and protein identification workflows, although the exact interpretation depends on method design, reference materials, and data quality [9] [10].
Lot traceability is also central to procurement review. NIST reference-material resources describe the role of certificates and lot or serial-number matching in reference-material documentation, which is relevant as a general documentation principle for laboratory recordkeeping [11] [12] [13]. ISO/IEC 17025 addresses competence and consistent operation of testing and calibration laboratories, while ISO 17034 addresses requirements for reference material producers; both standards are useful background for evaluating the quality environment behind analytical documentation [14] [15].
Storage documentation should be treated as part of quality review, not as a use protocol. Peer-reviewed peptide stability literature notes that peptides and proteins can be affected by storage conditions, material form, and time-dependent degradation pathways, so laboratory buyers should document supplier storage information and internal receiving records carefully [16] [17].
Published literature on Cartalax and related short peptides should be separated from product sourcing. Database records identify alanyl-glutamyl-aspartic acid and support molecular-identity review for Cartalax supplier documentation [2] [3]. Review literature discusses short peptides, gene-expression models, transporter-model hypotheses, and cell-differentiation research, but those publications do not establish use guidance for an RUO research material [4] [18].
Some short-peptide publications include in vitro, preclinical, computational, or review-based models. For example, published articles have examined short-peptide regulation in cell-culture systems, transporter-model feasibility, and differentiation-related research models [5] [6] [19]. Those research contexts can help scientists understand why a compound appears in the literature, but they should not be presented as benefits, outcomes, or guidance for any RUO product.
Other publications have evaluated AED or related ultrashort peptides in laboratory cell models, including fibroblast and stem-cell research contexts [20] [21] [22]. For procurement purposes, these citations should be read as scientific background only. The evidence landscape for Cartalax sourcing remains documentation-centered: identity records, analytical methods, COA review, RUO labeling, storage information, and lot traceability.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification | Database / analytical | Supports identification, not product-use claims |
| Short-peptide category context | Oligopeptide classification, ultrashort peptide models, and category-level literature | Review / computational / in vitro | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation / stability literature | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “Cartalax is discussed in published research related to short peptide and laboratory model literature.” | Describes literature context without making a product claim | “Cartalax helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy Cartalax for results.” |
| “Pure Lab Peptides supplies Cartalax as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies Cartalax for therapy.” |
| “The phrase buy Cartalax online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy Cartalax online for personal use.” |
| “Cartalax supplier documentation should include purity, identity, and lot-level information.” | Centers analytical review and procurement records | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents Cartalax 20mg as a research-use-only material for laboratory procurement. The product is listed with a ≥99% purity claim, lyophilized powder form, and batch-specific COA availability. Researchers should review the product page, RUO labeling, product details, Cartalax purity documentation, Cartalax supplier documentation, storage and handling information, and lot-level traceability before selecting any research material.
Review the Pure Lab Peptides Cartalax research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. For broader category review, qualified buyers can also review the Pure Lab Peptides research peptide collection, educational resources on the Pure Lab Peptides blog, and procurement-related shipping information at shipping and returns.
Buy Cartalax online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published Cartalax or short-peptide literature can provide scientific context, but it should not be treated as guidance for any RUO material. Procurement teams should separate research background from supplier documentation, product labeling, analytical testing, COA records, and laboratory recordkeeping.
A Cartalax purity percentage is only one part of quality review. Researchers should evaluate the stated purity together with identity testing, analytical method, lot number, product name, molecular information, and the batch-specific COA. Identity and purity are related, but they are not the same documentation question.
For research procurement, batch-specific documentation matters because it connects the received material to a particular lot. A general specification sheet can be useful, but a Cartalax COA should be reviewed with the lot number, test date, purity information, identity method, and product-form details.
Research-use-only labeling does not support human-use, animal-use, consumer-use, clinical, diagnostic, or veterinary positioning. RUO labeling indicates that the material belongs in controlled laboratory procurement workflows where documentation, traceability, storage records, and analytical review are central.
Supplier transparency should be demonstrated through documentation, not broad claims. Researchers evaluating Cartalax research-use-only procurement should prioritize a batch-specific COA, identity testing, purity documentation, lot traceability, product-form statements, and clear RUO labeling.
Researchers can buy Cartalax online for laboratory research by reviewing RUO suppliers that provide clear product labeling, batch-specific COA documentation, purity information, identity data, storage guidance, and lot traceability. Pure Lab Peptides lists Cartalax 20mg as a research-use-only material with batch-specific documentation available for procurement review.
Before buying Cartalax online, researchers should check RUO labeling, product name consistency, batch-specific COA availability, stated purity, analytical method, identity information, lot number matching, storage documentation, and supplier language. The supplier should present Cartalax as a laboratory research material, not as a consumer product.
A Cartalax COA matters because it helps researchers connect a listed product to batch-specific documentation. A useful COA should support review of the compound name, lot number, test date, purity information, identity method, and related analytical details. COA review supports procurement records and internal laboratory documentation.
Cartalax discussed on this page is intended for laboratory research use only and is not intended for human or animal consumption. Researchers should evaluate Cartalax research-use-only labeling, supplier documentation, COA availability, and storage information within controlled laboratory procurement workflows.
Research use only means Cartalax is positioned as a laboratory research material, not a consumer, clinical, diagnostic, veterinary, or therapeutic product. For procurement teams, RUO review centers on documentation: identity testing, purity support, batch-specific COA records, lot traceability, product-form details, and storage guidance.
Published literature about Cartalax, AED, or related short peptides should be interpreted as scientific context, not product-use guidance. Researchers may review database records, analytical references, in vitro literature, and category-level reviews while keeping procurement decisions focused on RUO labeling, COA documentation, identity testing, and supplier transparency.
Qualified researchers evaluating Cartalax should review product labeling, COA status, identity documentation, storage information, and supplier transparency. Review the Cartalax 20mg product page for RUO labeling, purity information, and available batch-specific documentation before selecting any research-use-only material.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.